Area of research
Immunology · Oncology
Research interest
Research focused on Immunotherapy and Cytotoxic T cell, with related work in Immune system, Cancer research, Chimeric antigen receptor. Notable publications include 'Cold Tumors: A Therapeutic Challenge for Immunotherapy', 'Development of NK cell-based cancer immunotherapies through receptor engineering', and 'IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer'.
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2
Development of NK cell-based cancer immunotherapies through receptor engineering
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods
IL-33 drives polyfunctionality and antitumor activity of a unique ST2+ NK cell population
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80<sup>+</sup> PDL1<sup>−</sup>)‐pDC subset negatively correlated with clinical outcomes in melanoma patients
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4 <sup>+</sup> and CD8 <sup>+</sup> T‐cell protective responses to breast cancer
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC
BDCA1<sup>+</sup> cDC2s, BDCA2<sup>+</sup> pDCs and BDCA3<sup>+</sup> cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients
Cold Tumors: A Therapeutic Challenge for Immunotherapy
Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage
Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay
Human XCR1+ Dendritic Cells Derived In Vitro from CD34+ Progenitors Closely Resemble Blood Dendritic Cells, Including Their Adjuvant Responsiveness, Contrary to Monocyte-Derived Dendritic Cells
Human natural killer cells promote cross‐presentation of tumor cell‐derived antigens by dendritic cells